(1)
Al-Ammiri, H. H.; Al-Derzi, A. R. Validity of Serum Toll-Like Receptor-2 (TLR-2) in Women With Breast Tumor. JFacMedBagdad 2013, 55 (2), 152-157. https://doi.org/10.32007/jfacmedbagdad.552645.